Dogwood Therapeutics Inc stock is traded at $1.04, with a volume of 166,773. It is down -2.36% in the last 24 hours and down -10.00% over the past month. Dogwood Therapeutics Inc is a development-stage biopharmaceutical company focused on developing new medicines to treat pain and neuropathy. The pipeline is focused on treating chronic neuropathic pain and neuropathy. The Company operates in one segment and is a pre-revenue, development-stage biopharmaceutical company focused on developing new medicines to treat pain and peripheral neuropathy associated with cancer.
Previous Close:
$1.06
Open:
$1.06
24h Volume:
166,773
Relative Volume:
1.38
Market Cap:
$39.57M
Revenue:
-
Net Income/Loss:
-$28.32M
P/E Ratio:
-
EPS:
-$10.60
Net Cash Flow:
-$15.52M
1W Performance:
-6.76%
1M Performance:
-10.00%
6M Performance:
-43.75%
1Y Performance:
-82.61%
1-Day Range:
$0.99$1.10
1-Week Range:
$0.99$1.20
52-Week Range:
$0.901$7.04
Dogwood Therapeutics Inc Stock (DWTX) Company Profile
Name
Dogwood Therapeutics IncSector
HealthcareIndustry
BiotechnologyPhone
(866) 620-8655Address
44 MILTON AVENUE, ALPHARETTA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS